Locoregional breast cancer recurrence following targeted intraoperative radiotherapy (IORT) for ductal carcinoma in situ (DCIS)

Protocol: 
AAAQ7853
Phase: 
II

Locoregional breast cancer recurrence following targeted intraoperative radiotherapy (IORT) for ductal carcinoma in situ (DCIS)

Are you Eligible? (Inclusion Criteria)

To be eligible for this trial, patients must be:
- Female 18 years old or older with DCIS suitable for breast conserving
surgery and radiotherapy
- single tumor size less than or equal to 2 cm , no axillary lymph node
involvement and no metastases
-amenable to follow-up for at least 5 years.
- No prior treatment

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States